Baxter International Inc. insider trading
BAXfinancial statementsForm 4 filings on EDGAR84 transactions since Nov 3, 2024
From August 6, 2026 to November 3, 2026, 0 insiders at Baxter International Inc. bought $0 of stock in the open market, and 0 sold $0. Officers and directors accounted for $0 of purchases and $0 of sales. The last reported transaction was a tax withholding by Hider Andrew P. on September 2, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through September 3, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $0Aug 6, 2026 – Nov 3, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Nov 3, 2026. Insider data through Nov 3, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
84 transactions from November 3, 2024 to November 3, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Hider Andrew P. | President and CEO, Director | tax withholding | 54,276 | $25.70 | $1M | 518,447 | Sep 3, 2026 |
| Sep 2, 2026 | Foster Julie | President, Front Line Care | tax withholding | 2,098 | $25.70 | $54K | 29,164 | Sep 3, 2026 |
| Sep 1, 2026 | Teaff James | President, CCS | tax withholding | 750 | $25.48 | $19K | 30,370 | Sep 3, 2026 |
| Jun 2, 2026 | Wallace Steven P. | President, Adv. Surgery | tax withholding | 153 | $18.68 | $3K | 70,128 | Jun 3, 2026 |
| Jun 2, 2026 | Teaff James | President, CCS | tax withholding | 321 | $18.68 | $6K | 31,063 | Jun 3, 2026 |
| Jun 1, 2026 | Zielinski Anita A | SVP, Interim CFO, CAO & Cntrlr | award | 13,426 | $0.00 | — | 59,714 | Jun 3, 2026 |
| May 5, 2026 | Wilkes David S. | Director | award | 12,836 | $0.00 | — | 37,076 | May 7, 2026 |
| May 5, 2026 | Wendell Amy McBride | Director | award | 12,836 | $0.00 | — | 44,235 | May 7, 2026 |
| May 5, 2026 | Schlichting Nancy M | Director | award | 12,836 | $0.00 | — | 34,994 | May 7, 2026 |
| May 5, 2026 | Morrison Patricia | Director | award | 12,836 | $0.00 | — | 42,386 | May 7, 2026 |
| May 5, 2026 | Shafer David Brent | Director | award | 12,836 | $0.00 | — | 72,804 | May 7, 2026 |
| May 5, 2026 | McDonnell Michael R. | Director | award | 12,836 | $0.00 | — | 14,647 | May 7, 2026 |
| May 5, 2026 | Craig Jeffrey A | Director | award | 12,836 | $0.00 | — | 23,662 | May 7, 2026 |
| May 5, 2026 | Ampofo William A. II | Director | award | 12,836 | $0.00 | — | 30,375 | May 7, 2026 |
| Mar 6, 2026 | Zielinski Anita A | SVP, CAO and Controller | tax withholding | 1,932 | $17.69 | $34K | 46,281 | Mar 10, 2026 |
| Mar 6, 2026 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | tax withholding | 2,848 | $17.69 | $50K | 75,045 | Mar 10, 2026 |
| Mar 6, 2026 | Rosenbloom David S. | EVP and General Counsel | tax withholding | 6,620 | $17.69 | $117K | 138,216 | Mar 10, 2026 |
| Mar 6, 2026 | Rasul Reazur | EVP,Group Pres,Healthcare | tax withholding | 12,674 | $17.69 | $224K | 125,557 | Mar 10, 2026 |
| Mar 6, 2026 | Grade Joel T. | EVP and CFO | tax withholding | 8,153 | $17.69 | $144K | 271,674 | Mar 10, 2026 |
| Mar 2, 2026 | Rasul Reazur | EVP,Group Pres,Healthcare | tax withholding | 1,614 | $19.69 | $32K | 138,231 | Mar 3, 2026 |
| Mar 2, 2026 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | tax withholding | 1,852 | $19.69 | $36K | 77,894 | Mar 3, 2026 |
| Mar 2, 2026 | Rosenbloom David S. | EVP and General Counsel | tax withholding | 1,336 | $19.69 | $26K | 144,837 | Mar 3, 2026 |
| Feb 27, 2026 | Hider Andrew P. | President and CEO, Director | award | 201,804 | $0.00 | — | 572,239 | Mar 3, 2026 |
| Feb 27, 2026 | Carlisle Cynthia | Executive Vice President, CHRO | award | 17,806 | $0.00 | — | 17,806 | Mar 3, 2026 |
| Feb 27, 2026 | Carlisle Cynthia | Executive Vice President, CHRO | award | 11,871 | $0.00 | — | 29,677 | Mar 3, 2026 |
| Feb 27, 2026 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | award | 23,742 | $0.00 | — | 79,748 | Mar 3, 2026 |
| Feb 27, 2026 | Rosenbloom David S. | EVP and General Counsel | award | 26,709 | $0.00 | — | 146,173 | Mar 3, 2026 |
| Feb 27, 2026 | Grade Joel T. | EVP and CFO | award | 42,735 | $0.00 | — | 279,828 | Mar 3, 2026 |
| Feb 27, 2026 | Zielinski Anita A | SVP, CAO and Controller | award | 30,864 | $0.00 | — | 48,214 | Mar 3, 2026 |
| Feb 13, 2026 | McDonnell Michael R. | Director | award | 1,811 | $0.00 | — | 1,811 | Feb 18, 2026 |
| Feb 9, 2026 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | award | 2,273 | $0.00 | — | 56,924 | Feb 11, 2026 |
| Feb 9, 2026 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | tax withholding | 918 | $21.73 | $20K | 56,006 | Feb 11, 2026 |
| Feb 9, 2026 | Rosenbloom David S. | EVP and General Counsel | tax withholding | 5,225 | $21.73 | $114K | 119,464 | Feb 11, 2026 |
| Feb 9, 2026 | Rosenbloom David S. | EVP and General Counsel | award | 17,055 | $0.00 | — | 124,689 | Feb 11, 2026 |
| Feb 9, 2026 | Rasul Reazur | EVP,Group Pres,Healthcare | award | 18,951 | $0.00 | — | 145,616 | Feb 11, 2026 |
| Feb 9, 2026 | Rasul Reazur | EVP,Group Pres,Healthcare | tax withholding | 5,770 | $21.73 | $125K | 139,846 | Feb 11, 2026 |
| Feb 9, 2026 | Grade Joel T. | EVP and CFO | tax withholding | 9,144 | $21.73 | $199K | 236,904 | Feb 11, 2026 |
| Feb 9, 2026 | Grade Joel T. | EVP and CFO | award | 30,504 | $0.00 | — | 246,048 | Feb 11, 2026 |
| Dec 12, 2025 | Mason Jeanne K | EVP, Chief HR Officer | tax withholding | 650 | $19.15 | $12K | 199,853 | Dec 16, 2025 |
| Dec 1, 2025 | Grade Joel T. | EVP and CFO | tax withholding | 8,288 | $19.08 | $158K | 215,151 | Dec 3, 2025 |
| Sep 2, 2025 | Sonig Alok | EVP,Group President,Pharma | tax withholding | 3,191 | $24.17 | $77K | 128,219 | Sep 4, 2025 |
| Sep 2, 2025 | Hider Andrew P. | President and CEO, Director | award | 236,237 | $0.00 | — | 236,237 | Sep 4, 2025 |
| Sep 2, 2025 | Hider Andrew P. | President and CEO, Director | award | 131,813 | $0.00 | — | 368,050 | Sep 4, 2025 |
| Sep 2, 2025 | Grade Joel T. | EVP and CFO | award | 102,712 | $0.00 | — | 222,560 | Sep 4, 2025 |
| Sep 2, 2025 | Borzi James W | EVP,Chief Supply Chain Officer | tax withholding | 1,848 | $24.17 | $45K | 71,948 | Sep 4, 2025 |
| Aug 19, 2025 | Shafer David Brent | Director | tax withholding | 31,337 | $24.33 | $762K | 59,446 | Aug 21, 2025 |
| Jun 2, 2025 | Rosenbloom David S. | EVP and General Counsel | tax withholding | 16,548 | $29.55 | $489K | 106,327 | Jun 4, 2025 |
| May 6, 2025 | Wilkes David S. | Director | award | 7,183 | $0.00 | — | 23,906 | May 8, 2025 |
| May 6, 2025 | Wendell Amy McBride | Director | award | 7,183 | $0.00 | — | 31,222 | May 8, 2025 |
| May 6, 2025 | Smith Cathy R | Director | award | 7,183 | $0.00 | — | 30,345 | May 8, 2025 |
Who the insiders are
Everyone who reported a transaction since November 3, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Rosenbloom David S. | EVP and General Counsel | Mar 6, 2026 | tax withholding | 138,216 | — | — | — |
| Grade Joel T. | EVP and CFO | Mar 6, 2026 | tax withholding | 271,674 | — | — | — |
| Rasul Reazur | EVP,Group Pres,Healthcare | Mar 6, 2026 | tax withholding | 125,557 | — | — | — |
| Soriano Maria Cecilia | Group Pres., ITT & Pharma. | Mar 6, 2026 | tax withholding | 75,045 | — | — | — |
| Hider Andrew P. | President and CEO, Director | Sep 2, 2026 | tax withholding | 518,447 | — | — | — |
| Zielinski Anita A | SVP, Interim CFO, CAO & Cntrlr | Jun 1, 2026 | award | 59,714 | — | — | — |
| Mason Jeanne K | EVP, Chief HR Officer | Dec 12, 2025 | tax withholding | 199,853 | — | — | — |
| Sonig Alok | EVP,Group President,Pharma | Sep 2, 2025 | tax withholding | 128,219 | — | — | — |
| Borzi James W | EVP,Chief Supply Chain Officer | Sep 2, 2025 | tax withholding | 71,948 | — | — | — |
| Knight Heather | EVP, Chief Operating Officer | Mar 6, 2025 | tax withholding | 141,688 | — | — | — |
| Shafer David Brent | Interim CEO and Chair, Director | May 5, 2026 | award | 72,804 | — | — | — |
| Teaff James | President, CCS | Sep 1, 2026 | tax withholding | 30,370 | — | — | — |
| Wilkes David S. | Director | May 5, 2026 | award | 37,076 | — | — | — |
| Wendell Amy McBride | Director | May 5, 2026 | award | 44,235 | — | — | — |
| Schlichting Nancy M | Director | May 5, 2026 | award | 34,994 | — | — | — |
| Morrison Patricia | Director | May 5, 2026 | award | 42,386 | — | — | — |
| McDonnell Michael R. | Director | May 5, 2026 | award | 14,647 | — | — | — |
| Craig Jeffrey A | Director | May 5, 2026 | award | 23,662 | — | — | — |
| Ampofo William A. II | Director | May 5, 2026 | award | 30,375 | — | — | — |
| Carlisle Cynthia | Executive Vice President, CHRO | Feb 27, 2026 | award | 17,806 | — | — | — |
| Toth Christopher A. | EVP, Group Pres, Kidney Care | Jan 31, 2025 | tax withholding | 105,186 | — | — | — |
| Foster Julie | President, Front Line Care | Sep 2, 2026 | tax withholding | 29,164 | — | — | — |
| Wallace Steven P. | President, Adv. Surgery | Jun 2, 2026 | tax withholding | 70,128 | — | — | — |
| Smith Cathy R | Director | May 6, 2025 | award | 30,345 | — | — | — |
| Rusckowski Stephen H | Director | May 6, 2025 | award | 16,499 | — | — | — |
| Oesterle Stephen N. | Director | May 6, 2025 | award | 35,847 | — | — | — |
| Almeida Jose E | Chairman, CEO, President | Dec 13, 2024 | tax withholding | 243,589 | — | — | — |
Questions
Are Baxter International Inc. insiders buying or selling?
Over the twelve months to November 3, 2026, no insider at Baxter International Inc. sold stock in the open market, and no insider bought. Purchases and sales netted to zero. Only open-market purchases and sales are counted.
Who sold the most Baxter International Inc. stock in the last year?
No insider sold Baxter International Inc. stock in the open market in the twelve months to November 3, 2026.
Do Baxter International Inc. executives sell under 10b5-1 plans?
There were no open-market sales in the last twelve months.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on Baxter International Inc.
- Baxter International Inc. financial statements
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.